Skip to Main Content

As 2019 begins, STAT reporters are taking a look at the stories they’re most eager to track during the year. Find all our “three to watch” series here

On paper, biotech had quite a year in 2018.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • From “Is there demand ..,” in defense of Moderna (New Years resolution – “Be Kind”), one may observe that a retreating tide lowers all boats as well. It will be instructive to see where both MRNA nad the NASDAQ are at the end of Q1 and Q2.

Comments are closed.